Beta Bionics (BBNX) Cash from Investing Activities (2024 - 2026)
Beta Bionics (BBNX) posted Cash from Investing Activities of $26.9 million for Q2 2026, up 23.33% sequentially from $21.8 million in Q1 2026, and up 336.3% YoY from $6.2 million in Q2 2025.
Beta Bionics (BBNX) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Beta Bionics has reported Cash from Investing Activities for 3 years, with the latest figure at $26.9 million in Q2 2026.
- Quarterly Cash from Investing Activities rose 336.3% year-over-year to $26.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $58.9 million (up 131.44% YoY) and the FY2025 annual result came in at -$162.8 million, down 4583.69% from the prior year.
- Cash from Investing Activities rose to $26.9 million in Q2 2026 per BBNX's latest filing, from $21.8 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $26.9 million in Q2 2026 and troughed at -$179.1 million in Q1 2025.
- A 3-year average of -$11.8 million and a median of $6.9 million in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities sank 2443.3% in 2025, then jumped 336.3% in 2026.
- Over 3 years, Cash from Investing Activities stood at -$29.7 million in 2024, then jumped by 102.22% to $658000.0 in 2025, then surged by 3993.16% to $26.9 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $26.9 million, $21.8 million, and $658000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Beta Bionics | 837.47 Mn | 656.98 Mn | 18.90 Mn | 26.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.93 Mn |
| Jun 30, 2026 | 26.93 Mn |
| Mar 31, 2026 | 21.84 Mn |
| Mar 31, 2026 | 21.84 Mn |
| Dec 31, 2025 | 658,000.00 |
| Dec 31, 2025 | 658,000.00 |
| Sep 30, 2025 | 9.49 Mn |
| Sep 30, 2025 | 9.49 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | -179.12 Mn |
| Mar 31, 2025 | -179.12 Mn |
| Dec 31, 2024 | -29.66 Mn |
| Dec 31, 2024 | -29.66 Mn |
| Sep 30, 2024 | 15.24 Mn |
| Sep 30, 2024 | 15.24 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Mar 31, 2024 | 7.64 Mn |